Arsenic Induced Miotic Arrest Associated Apoptosis

砷诱导的缩瞳抑制相关的细胞凋亡

基本信息

  • 批准号:
    7414686
  • 负责人:
  • 金额:
    $ 0.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-08-01 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Arsenic is a natural contaminant of drinking water in many parts of the world, is a known human carcinogen and is #1 on the EPA list of hazardous chemicals. Cancers most often associated with chronic arsenism are squamous and basal cell carcinomas of the skin. How arsenic causes cancer is unknown. However, the National Research Council Report on Arsenic in Drinking Water concluded that the most likely mode of action is induction of numerical and structural chromosomal abnormalities. Arsenite, the carcinogenic form of arsenic found in drinking water, disrupts mitosis causing an anaphase delay and induces aneuploidy in normal diploid human fibroblasts and peripheral blood lymphocytes, and mitotic arrest associated apoptosis (MAAA) in p53 deficient human fibroblasts. The sensitivity of p53 deficient human cells to arsenite induced MAAA suggests that the mechanism of arsenite carcinogenesis is different than sunlight induced skin carcinogenesis in which p53 mutation is an early and common event. The hypothesis to be investigated is that p53 relieves the arsenite-induced anaphase block by activation of the G2 checkpoint response which inactivates cyclin B/cdc2 and derepresses the mitotic exit network and allow the cells to escape arsenite induced MAAA. It is the prevention of apoptosis in arsenic intoxicated cells that allows genetic instability (aneuploidy) after mitotic disruption. Identification of the cellular factors that interact with p53 or the p53 regulated genes to prevent mitotic arrest associated apoptosis and to allow cells to proceed through mitosis with a delay will provide valuable information regarding the mode of action of arsenite. The specific aims proposed are: 1.) Determine activation of the G2 checkpoint pathway in p53(+) and p53(-) cells arrested by arsenite in mitosis; 2.) Test by overexpression and targeted knockdown of G2 checkpoint proteins the role of G2 checkpoint activation in the escape from arsenite induced anaphase block; 3.) Test whether arsenic associated skin tumors are p53 wild type or mutant. The results of these studies will identify players mediating release from arsenite induced mitotic arrest, and will provide valuable information on the mechanism of arsenic induced carcinogenesis, clues to the usefulness of arsenite as a chemotherapeutic agent and valuable information on the mode of action of mitosis disrupting drugs in killing human cells.
说明(申请人提供):砷是世界许多地区饮用水的天然污染物,是已知的人类致癌物质,在美国环保局的危险化学品清单上排名第一。最常与慢性砷中毒有关的癌症是皮肤鳞状细胞癌和基底细胞癌。砷是如何致癌的,目前尚不清楚。然而,国家研究委员会关于饮用水中砷的报告得出结论,最有可能的作用模式是诱导数字和结构染色体异常。亚砷酸盐是饮用水中发现的致癌形式的砷,它破坏有丝分裂,导致后期延迟,并诱导正常二倍体人成纤维细胞和外周血淋巴细胞的非整倍体,以及p53基因缺陷的人成纤维细胞的有丝分裂停滞相关凋亡(MAAA)。P53基因缺陷的人细胞对亚砷酸盐诱导的MAAA的敏感性表明,亚砷酸盐致癌的机制不同于阳光诱导的皮肤癌,其中P53突变是一种早期和常见的事件。需要研究的假设是,P53通过激活G2检查点反应来解除亚砷酸盐诱导的后期阻断,G2检查点反应使细胞周期蛋白B/cdc2失活,并降低有丝分裂退出网络的压力,使细胞能够逃避亚砷酸盐诱导的MAAA。正是对砷中毒细胞的凋亡的预防,使得有丝分裂中断后的遗传不稳定(非整倍体)。识别与P53或P53调控基因相互作用的细胞因子,以防止有丝分裂停滞相关的细胞凋亡,并允许细胞延迟进行有丝分裂,将为了解亚砷酸盐的作用模式提供有价值的信息。提出的具体目标是:1.在有丝分裂过程中,检测亚砷酸盐阻断的p53(+)和p53(-)细胞中G2检查点通路的激活;通过G2检查点蛋白的过度表达和靶向敲除来检验G2检查点激活在亚砷酸盐诱导的后期阻断逃逸中的作用;检测与砷相关的皮肤肿瘤是野生型还是突变型。这些研究的结果将有助于确定从亚砷酸盐诱导的有丝分裂抑制中释放的分子,并将为砷致癌机制提供有价值的信息,为亚砷酸盐作为化疗药物的有效性提供线索,并为有丝分裂干扰药物杀伤人类细胞的作用模式提供有价值的信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J CHRISTOPHER STATES其他文献

J CHRISTOPHER STATES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J CHRISTOPHER STATES', 18)}}的其他基金

University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10386901
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10600111
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10560120
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:
Alternative splicing in arsenical skin carcinogenesis
砷皮肤癌发生中的选择性剪接
  • 批准号:
    9979035
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    9917940
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10600112
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10217134
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10217135
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:
University of Louisville Center for Integrative Environmental Health Sciences
路易斯维尔大学综合环境健康科学中心
  • 批准号:
    10817400
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10386902
  • 财政年份:
    2020
  • 资助金额:
    $ 0.54万
  • 项目类别:

相似海外基金

Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
  • 批准号:
    10887038
  • 财政年份:
    2023
  • 资助金额:
    $ 0.54万
  • 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
  • 批准号:
    10877239
  • 财政年份:
    2023
  • 资助金额:
    $ 0.54万
  • 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
  • 批准号:
    MR/X007979/1
  • 财政年份:
    2023
  • 资助金额:
    $ 0.54万
  • 项目类别:
    Research Grant
Cell competition, aneuploidy, and aging
细胞竞争、非整倍性和衰老
  • 批准号:
    10648670
  • 财政年份:
    2023
  • 资助金额:
    $ 0.54万
  • 项目类别:
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
  • 批准号:
    10735074
  • 财政年份:
    2023
  • 资助金额:
    $ 0.54万
  • 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
  • 批准号:
    10538074
  • 财政年份:
    2022
  • 资助金额:
    $ 0.54万
  • 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
  • 批准号:
    10537275
  • 财政年份:
    2022
  • 资助金额:
    $ 0.54万
  • 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
  • 批准号:
    10661533
  • 财政年份:
    2022
  • 资助金额:
    $ 0.54万
  • 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
  • 批准号:
    10467260
  • 财政年份:
    2022
  • 资助金额:
    $ 0.54万
  • 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
  • 批准号:
    10366610
  • 财政年份:
    2022
  • 资助金额:
    $ 0.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了